Shondera Drayton v. Mead Johnson & Company LLC

Court of Appeals for the Seventh Circuit·Decided July 28, 2026·No. 25-2324·Published·Ripple

Opinion

In the

United States Court of Appeals For the Seventh Circuit ____________________ No. 25-2322 IN RE: ABBOTT LABORATORIES, et al., PRETERM INFANT NUTRITION PRODUCTS LIABILITY LITIGATION

TERRAINE ABDULLAH, on her own behalf and as Parent and Natural Guardian of H.S., a minor,

Plaintiff-Appellant,

v.

MEAD JOHNSON & COMPANY LLC, et al., Defendants-Appellees. ____________________ No. 25-2323 HOLLI CARTER, on her own behalf and as Parent and Natural Guardian of J.C., a minor,

MEAD JOHNSON & COMPANY LLC, et al., Defendants-Appellees. ____________________ 2 Nos. 25-2322, 25-2323, 25-2324, 25-2325 & 25-2327

No. 25-2324 SHONDERA DRAYTON, on her own behalf and as Parent and Natural Guardian of A.D., a minor, Plaintiff-Appellant,

MEAD JOHNSON & COMPANY LLC, et al., Defendants-Appellees. ____________________ No. 25-2325 GINA WIEGER, on her own behalf and as Parent and Natural Guardian of S.P., a minor,

MEAD JOHNSON & COMPANY LLC, et al., Defendants-Appellees. ____________________ No. 25-2327 ALICE STILLS, on her own behalf and as Parent and Natural Guardian of M.E., a minor,

MEAD JOHNSON & COMPANY LLC, et al., Defendants-Appellees. Nos. 25-2322, 25-2323, 25-2324, 25-2325 & 25-2327 3

____________________

Appeals from the United States District Court for the Northern District of Illinois, Eastern Division. Nos. 1:22-cv-00071, 1:24-cv-11759, 1:24-cv-11760, 1:24-cv-11761, 1:24-cv-11763, 1:24-cv-11765 — Rebecca R. Pallmeyer, Judge. ____________________

ARGUED FEBRUARY 24, 2026 — DECIDED JULY 28, 2026 ____________________

Before RIPPLE, KOLAR, and MALDONADO, Circuit Judges. RIPPLE, Circuit Judge. These five cases are a small subsec- tion of several hundred similar cases against Abbott Labora- tories (“Abbott”), Mead Johnson & Company LLC, and Mead Johnson Nutrition Company (together, “Mead”).1 Many of these, including these five cases now before us, have been consolidated in an MDL proceeding in the Northern District of Illinois.2 The cases before us were filed originally in Pennsylvania state court and were later transferred to federal court by the defendants. Even though there were non-diverse defendants, the district court believed that its subject matter jurisdiction was secure under 28 U.S.C. § 1332. It took the view that the

1 For the purposes of this appeal, we will refer primarily to the record in

Abdullah v. Mead Johnson & Co. LLC, et al., No. 1:24-cv-11759 (N.D. Ill.) (hereinafter “Abdullah R.”), because the relevant records in the five cases are substantially the same. When necessary, we will reference the records in the other four cases by plaintiff’s name. 2 Transfer Order, In re: Abbott Lab’ys, et al., Preterm Infant Nutrition Prods.

Liab. Litig., MDL No. 3026, R.119 (J.P.M.L. Apr. 8, 2022). 4 Nos. 25-2322, 25-2323, 25-2324, 25-2325 & 25-2327

non-diverse parties, Pennsylvania Hospital and related enti- ties,3 had been fraudulently joined because the plaintiffs had not demonstrated sufficient intent to pursue claims against them. The district court denied remand to the state court, but, recognizing the novelty of its decision, certified its order for interlocutory appeal under 28 U.S.C. § 1292(b). Specifically, the district court certified two questions for appeal: (1) whether a plaintiff’s failure, through their lit- igation actions, to demonstrate a real or good faith intent to pursue a claim against a non-di- verse defendant, is a basis for finding that the non-diverse defendant was fraudulently joined; and if so, (2) whether a plaintiff’s failure over many months to pursue unanswered interroga- tories; taking of a singular, perfunctory deposi- tion; and a verbal representation that they will not seek an appeal of a dismissal of their action against the non-diverse defendant, meets the standard for finding ‘no real intent’ fraudulent joinder.4

3 The plaintiffs named the Pennsylvania Hospital of the University of

Pennsylvania Health System and the Trustees of the University of Penn- sylvania as defendants. We will refer to these entities collectively as “Pennsylvania Hospital” throughout the opinion. 4 Abdullah R.27 at 15. Nos. 25-2322, 25-2323, 25-2324, 25-2325 & 25-2327 5

The defendants then petitioned this court for interlocutory review. We granted the petition and consolidated the appeals for briefing and disposition. The courts of appeals have restricted fraudulent joinder to two situations: where the plaintiff has lied about jurisdic- tional facts, and where the plaintiff has no chance of success against the non-diverse defendant, taking all facts and law in the plaintiff’s favor. Consistent with other circuits’ ap- proaches to fraudulent joinder,5 we now hold that the district court’s view of the fraudulent joinder doctrine is not con- sistent with the case law of the Supreme Court or of the courts of appeals, including this court.6 Its belief that the plaintiffs had shown insufficient intent to pursue the litigation against Pennsylvania Hospital to judgment is not an appropriate ba- sis upon which to predicate a determination of fraudulent joinder. Accordingly, we reverse the decision of the district court and remand the cases for further proceedings consistent with this opinion. I BACKGROUND A The defendants, Mead and Abbott, manufacture cow’s milk-based infant formula products (“Enfamil” and “Simi- lac,” respectively).7 Each of the plaintiffs is the parent of a

5 See infra note 18.

6 While many circuits have addressed fraudulent joinder more generally,

we have not found any published cases in which a circuit court addressed the theory of fraudulent joinder at issue here. 7 Abdullah R.1-1, Ex. A-2 at 5. 6 Nos. 25-2322, 25-2323, 25-2324, 25-2325 & 25-2327

child who was born prematurely at Pennsylvania Hospital in Philadelphia. The infants were fed either Similac or Enfamil during their hospital stay and subsequently developed ne- crotizing enterocolitis (“NEC”), resulting in long-term serious medical conditions. NEC is a gastrointestinal disorder that develops when harmful bacteria breach the walls of the intes- tine and cause inflammation and tissue death. The disease has a thirty percent mortality rate. The cases now before us were filed in Pennsylvania state court on March 24, 2022. Plaintiffs Abdullah, Drayton, and Stills are citizens of Pennsylvania. Plaintiffs Carter and Wieger are citizens of New Jersey.8 Each complaint was filed against Mead, Abbott, and Pennsylvania Hospital and alleges that the infant children developed NEC after being fed cow’s milk-based baby formula produced by Abbott or Mead. The parents also allege that Pennsylvania Hospital failed to warn parents about the risk of NEC associated with cow’s milk- based products and that it failed to develop policies to protect patients from exposure to NEC. Shortly after the complaints were filed, Abbott removed the cases for the first time. The cases were removed to the Eastern District of Pennsylvania and then transferred to MDL No. 3026 in the Northern District of Illinois. The plaintiffs moved for remand and succeeded. The district court held that because the plaintiffs stated potentially viable claims against Pennsylvania Hospital, the doctrine of fraudulent joinder did not apply, and the federal district court lacked jurisdiction. The cases returned to Pennsylvania state court on January 6, 2023. There, the parties began to conduct discovery, and

8 Carter R.1-1, Ex. A-2 at 5; Wieger R.1-1, Ex. A-2 at 5. Nos. 25-2322, 25-2323, 25-2324, 25-2325 & 25-2327 7

Pennsylvania Hospital filed its “preliminary objections” (the Pennsylvania law analogue to a motion to dismiss).

Free access — add to your briefcase to read the full text and ask questions with AI

Shondera Drayton v. Mead Johnson & Company LLC, (7th Cir. 2026).

Shondera Drayton v. Mead Johnson & Company LLC (Shondera Drayton v. Mead Johnson & Company LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Jacqueline D. Henderson v. Washington National
454 F.3d 1278 (Eleventh Circuit, 2006)
Strawbridge v. Curtiss
7 U.S. 267 (Supreme Court, 1806)
Ex Parte Bollman and Swartwout
8 U.S. 75 (Supreme Court, 1807)
Alabama Great Southern Railway Co. v. Thompson
200 U.S. 206 (Supreme Court, 1906)
Wecker v. National Enameling & Stamping Co.
204 U.S. 176 (Supreme Court, 1907)
Illinois Central Railroad v. Sheegog
215 U.S. 308 (Supreme Court, 1909)
American Car & Foundry Co. v. Kettlehake
236 U.S. 311 (Supreme Court, 1915)
Great Northern Railway Co. v. Alexander
246 U.S. 276 (Supreme Court, 1918)
Wilson v. Republic Iron & Steel Co.
257 U.S. 92 (Supreme Court, 1921)
Walton v. Bayer Corporation
643 F.3d 994 (Seventh Circuit, 2011)
Brown v. Eli Lilly and Co.
654 F.3d 347 (Second Circuit, 2011)
R. Michael Stillwell v. Allstate Insurance Company
663 F.3d 1329 (Eleventh Circuit, 2011)
Dutcher v. Matheson
733 F.3d 980 (Tenth Circuit, 2013)
Schur v. L.A. Weight Loss Centers, Inc.
577 F.3d 752 (Seventh Circuit, 2009)
Leonard v. St. Joseph Lead Co.
75 F.2d 390 (Eighth Circuit, 1935)